Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 3
1(16.7%)
6Total
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07531303Not Yet Recruiting

VenusP-Valve™ System Long-term Follow-up 6-10 Years

Role: lead

NCT06010563Not ApplicableRecruiting

VenusP-Valve Pivotal Study (PROTEUS STUDY)

Role: lead

NCT05835349Recruiting

Observational Study of Venus P-Valve

Role: lead

NCT05991271Not ApplicableNot Yet Recruiting

Venus-Vitae Pivotal Study Smart-Align Study

Role: lead

NCT02846753Not ApplicableUnknown

Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts

Role: lead

NCT04722796Not ApplicableRecruiting

HANGZHOU Solution in Bicuspid AS Undergoing TAVR

Role: collaborator

NCT02071654Phase 3Unknown

Efficacy and Safety of Venus P-valve to Treat RVOT Stenosis With Pulmonary Regurgitation

Role: lead

NCT01683474Not ApplicableUnknown

Safety and Performance of TAVI of Venus MedTech Aortic Valve Prosthesis

Role: lead

All 8 trials loaded